Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Revenue - Disaggregation of Revenue (Details)

v3.24.2.u1
Note 3 - Revenue - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Total revenue $ 0 $ 20,055 $ 53 $ 21,991
Pfizer [Member]        
Total revenue 0 3,486 6 4,909
Astra Zeneca A B [Member]        
Total revenue 0 4,056 0 4,490
Les Laboratoires Servier And Institut De Recherches Internationales Servier [Member]        
Total revenue 0 (31) 47 (105)
Genentech [Member]        
Total revenue $ 0 $ 12,544 $ 0 $ 12,697